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Familial tylosis (focal non-epidermolytic palmar and plantar hyperkeratosis) with squamous cell carcinoma of the oesophagus (TOC) is a rare autosomal dominant disorder (OMIM 148500) that was first described in a family from Liverpool. 1 Other families have since been described from America, Germany, Brazil, Spain and Finland. 2 Three gain-of-function missense variants in the RHBDF2-gene, which encodes the inactive rhomboid protease, iRhom2, have been reported to segregate with TOC in four families of European descent. 1, 2, 3 We here describe the first African family with tylosis and two cases of oesophageal cancer ( Figure 1A ), who carry a novel RHBDF2 heterozygous germ-line variant. Two studies have shed more light on the effect of these pathogenic gain-of-function missense variants. One study noted an increase in the activity of the metalloprotease, ADAM17, in TOC epidermal keratinocytes, which significantly upregulated the shedding of EGF-family growth factors as well as pro-inflammatory cytokines. 4 The second study found that the wild type iRhom2 protein is short-lived, and that gain-of-function variants increased the stability of the variant protein. This in turn led to metalloprotease-independent secretion of EGFR family ligands, including amphiregulin. This growth factor is upregulated in cancers and is known to provide strong autocrine stimulation of keratinocyte growth. 5 The variants induced accelerated wound-healing in vivo, and accelerated tumourigenesis. All of this is suggestive of an 5 upregulated wound-healing state in TOC patients' epithelia that are exposed to stress (wounding). It seems plausible that known risk factors for SCCO (such as alcohol and tobacco consumption) are also applicable to carcinogenesis in this and other families with TOC. The association of tobacco use with the occurrence of SCCO in the families is supported by the American family, where seven of the eight patients with SCCO had either smoked or chewed
